Respondents Show Significant Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications

2016 Global Survey on Clinical Next-generation Sequencing

Published: 5 May 2017

Next-generation sequencing and the use of genomics in diagnosis and treatment have generated many headlines in recent years, both for advancements on the research front, as well as in the development of diagnostics and pharmaceutical products that leverage genomics in oncology and other early-adopting fields. The question is no longer “if” or even “when” genomics will move bench to bedside, it’s happening now. It is imperative that healthcare providers position to integrate genomics and other ‘omics’ information into standard care today, so that their patients don’t miss out tomorrow.

Sign in to read the rest of this article

Not signed up? Register now Forgot your password?

Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..